Breakthrough could make 'smart drugs' effective for many cancer patients
(Medical Xpress) -- Newcastle and Harvard University reseachers have found that blocking a key component of the DNA repair process could extend the use of a new range of 'smart' cancer drugs called PARP inhibitors.
PARP inhibitors have been showing great promise in clinical trials for patients with breast, ovarian and prostate cancers caused by mutations in a gene called BRCA1. They work by blocking the action of PARP a molecule involved in the repair of damaged DNA.
By themselves, PARP inhibitors are unable to kill cancer cells but when used to target cancer cells that lack a protein normally produced by the BRCA1 gene, which is also involved in DNA repair, the two factors act together to attack the cancer cell. They are no longer able to repair DNA damage, ultimately leading them to die.
But, BRCA deficient cancers only account for a small proportion of all cancers. To improve the effectiveness and range of PARP inhibitors the researchers looked at whether artificially recreating the effect of losing BRCA1 by blocking a key controller of the cell cycle, Cdk1, would have the same effect.
Cdk1 plays an important role in repairing DNA by switching on BRCA1 in response to DNA damage. So when the researchers blocked the action of Cdk1 and treated the cells with PARP inhibitors the same two-pronged effect was seen in cells not previously affected by PARP inhibitors. The research is published in Nature Medicine.
Professor Nicola Curtin from Newcastle University, whose early work, funded by Cancer Research UK, linked PARP inhibitors and BRCA mutations, said: Our research shows how blocking Cdk1 compromises DNA repair in cancer cells, making them sensitive to PARP inhibitors. We were also able to show that this approach only targeted cancer cells, so if we are able to develop an effective Cdk1 drug we could have a more targeted treatment with fewer side effects.
Now we need to take this research in the lab and develop an effective drug that can block Cdk1, so more patients can benefit from treatment with PARP inhibitors.
Dr Lesley Walker, director of cancer information at Cancer Research UK, said: Cancer Research UK scientists have played a central role over the past two decades in developing PARP inhibitors. While they were originally designed to enhance the DNA damaging effects of chemotherapy and radiotherapy on cancer cells, where part of the DNA repair mechanism was already damaged, we are seeing they could be used to treat a wider range of cancers than previously thought. If the researchers are able to develop an effective drug to block Cdk1 we could have a powerful new tool to treat cancer patients.
More information: Johnson, N et al, Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition, Nature Medicine (2011)
Provided by Newcastle University
- Synthetic lethality: A new way to kill cancer cells Feb 22, 2010 | not rated yet | 0
- New test for ovarian cancer patients Nov 09, 2010 | not rated yet | 0
- New class of cancer drugs could work in colon cancers with genetic mutation, study finds Apr 25, 2011 | not rated yet | 0
- Heat helps cancer drugs battle cancer May 10, 2011 | not rated yet | 0
- New route to killing cancer gets a test run Jun 24, 2010 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
17 hours ago Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
Breast cancer characterized as "triple negative" carries a poor prognosis, with limited treatment options. In some cases, chemotherapy doesn't kill the cancer cells the way it's supposed to. New research from Western University ...
Cancer 4 hours ago | 5 / 5 (2) | 0
Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression. The findings ...
Cancer 4 hours ago | not rated yet | 0
Even while being dragged to its destruction inside a cell, a cancer-promoting growth factor receptor fires away, sending signals that thwart the development of tumor-suppressing microRNAs (miRNAs) before it's dissolved, researchers ...
Cancer 5 hours ago | not rated yet | 0 |
Treating pediatric leukemia patients with a liposomal formulation of anthracycline-based chemotherapy at a more intense-than-standard dose during initial treatment may result in high survival rates without causing any added ...
Cancer 9 hours ago | not rated yet | 0
Scientists have uncovered a survival mechanism that occurs in breast cells that have just turned premalignant-cells on the cusp between normalcy and cancers-which may lead to new methods of stopping tumors.
Cancer 9 hours ago | not rated yet | 0 |
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...
4 hours ago | 4.7 / 5 (3) | 0 |
Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.
7 hours ago | 5 / 5 (1) | 2 |
Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as ...
7 hours ago | 5 / 5 (2) | 0 |
(HealthDay)—Type 2 diabetes is more aggressive in children than adults, with signs of serious complications seen just a few years after diagnosis, new research finds.
1 hour ago | not rated yet | 0
A brief visual task can predict IQ, according to a new study. This surprisingly simple exercise measures the brain's unconscious ability to filter out visual movement. The study shows that individuals whose ...
9 hours ago | 4.9 / 5 (7) | 0 |
Little is known about why asthma develops, how it constricts the airway or why response to treatments varies between patients. Now, a team of researchers at Weill Cornell Medical College, Columbia University Medical Center ...
8 hours ago | not rated yet | 0 |